Posts by Sandra Ansanay-Alex
HAYA Therapeutics Raises $65 Million in Series A Funding
The Series A round is led by Sofinnova Partners and Earlybird Venture Capital with syndicate including Eli Lilly and Company. The funding will help advance clinical development of heart failure lead candidate and expand platform targeting the regulatory genome. HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram…
Read MoreCarewell Wins the 2025 PERL Trophy
The 23rd edition of the Prix Entreprendre Lausanne Région (PERL) took place on Wednesday 7 May, at Beaulieu-Lausanne, gathering around 300 leaders from politics, business, and academia. The prestigious Lausanne Région Trophy, worth CHF 50,000, was awarded to Carewell, a company based in Pully, for its innovative project at the intersection of technology and social…
Read MoreSwiss Medical Network joins the Mayo Clinic Care Network
Swiss Medical Network (Vaud – Switzerland) and Mayo Clinic are proud to announce that seven clinics and centres of Swiss Medical Network have joined the Mayo Clinic Care Network, becoming the first healthcare provider in Western Europe to enter the collaboration. The agreement includes Clinique de Genolier, Privatklinik Bethanien in Zurich, Clinica Sant’Anna in Lugano…
Read MoreWorld Vaccine Congress
World Vaccine Congress is taking place from 13 to 16 October in Amsterdam From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress. Learn from world KOLs in vaccines on the latest in technology platforms, global health,…
Read MoreHealthcare Innovation World Cup®
Apply before 12 September 2025 for the Healthcare Innovation World Cup® at MEDICA The Healthcare Innovation World Cup® focuses on groundbreaking solutions in the fields of Smart Health Devices, Medical Wearables, and Digital Biomarkers. Here’s what you can expect: 12 exclusive pitch slots at the grand finale on the biggest stage at MEDICA (MEDICA…
Read MoreMEDICA Start-up COMPETITION
Apply before 12 September 2025 for the MEDICA Start-up Competition Whether it’s AI in healthcare, robotics, health apps, or lab diagnostics, your innovation matters in the 14th MEDICA Start-up Competition! Pitch slots for the Top 12 Medical Start-ups 2025 on November 18, 2025 (3–5 PM) at the MEDICA INNOVATION FORUM International visibility, free marketing…
Read MoreSwiss Biotech Sector Shows Strength and Growth in 2024
Despite a challenging global market environment, the Swiss biotech sector once again demonstrated strength and resilience in 2024, as detailed in the newly released 2025 Swiss Biotech Report presented on 5 May 2025 during the Swiss Biotech Days. Co-authored by the Swiss Biotech Association, EY, and eight partner organizations, the report offers a deep dive…
Read MoreOncoSwab Secures CHF 1.3 Million Innosuisse Grant to Advance Lung Cancer Early Detection
OncoSwab, a Jura-based startup pioneering non-invasive cancer diagnostics, has secured a CHF 1.3 million Innosuisse grant to fund upcoming clinical trials in partnership with Inselspital Bern. The grant will enable OncoSwab to accelerate the clinical validation of its nasal fluid-based biomarker test — a revolutionary approach to the early detection of lung cancer. Addressing…
Read MoreMedical devices: Switzerland soon aligned with the FDA?
The Swiss government is working on a simplified validation procedure for medical devices that have already been authorised by the US FDA – involving private bodies in the assessment. During a session on 30 April 2025, the Federal Council has laid the groundwork for a wider supply of medical devices. The aim is…
Read Moreilmac
Ilmac will take place from 16 to 18 September 2025 in Hall 1.0 at Messe Basel With the promise ‘Inspiring the Future of Chemistry and Life Sciences’, Ilmac promotes the development of new ideas and solutions and presents the latest trends from research and industry at the important locations of Basel and Lausanne. Ilmac…
Read More